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Abstract 
Nuclear factor-kappa B (NF-κB) is a transcription factor that becomes functional when 
any two of its five component proteins (p50, p52, p65, c-Rel, and RelB) join together. NF-κB 
plays an important role in bringing out cell proliferation, or cell growth. When NF-κB 
malfunctions and becomes hyperactive, excessive NF-κB activity promotes abnormally high cell 
growth, which is a symptom of cancer. Because of its tie to cancer, NF-κB is commonly 
subjected to modification to curb cancer growth. In this project, each component protein of NF-
κB was degraded via a method called RNAi to see if it would have any negative influence on 
NF-κB activity of glioblastoma, or brain cancer, cells. It was found that degradation of p50 and 
p52 significantly reduced NF-κB activity while the remaining three failed to produce significant 
reduction. 
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Introduction 
Nuclear factor-kappa B (NF-κB) is a transcription factor that functions as a dimer unit, 
and its component proteins include p50, p52, p65, c-Rel, and RelB. Once activated, NF-κB plays 
an important role in initiating the activation of genes responsible for apoptosis (cell death), cell 
proliferation, and drug resistance. NF-κB: 1) induces resistance to apoptosis through 
upregulating expression of Inhibitors of Apoptosis (IAPs) [Takahashi et al. 1998]; 2) promotes 
cell proliferation by affecting several genes involved in cell cycle such as those of cyclin family 
[Guttridge et al. 1999]; and 3) bestows chemo/radio-resistance to cells by causing expression of 
multidrug resistance P-glycoprotein [Dolcet et al. 2005]. Since NF-κB is involved in cell growth 
and drug resistance, abnormal NF-κB puts cells in danger of becoming cancer cells. 
NF-κB has four roles in tumor initiation and development: 1) it promotes cancer cell 
survival through stimulating cell proliferation and preventing apoptosis, 2) it regulates proteins 
involved in tumor angiogenesis (synthesis of blood vessels) such as vascular endothelial growth 
factor (VEGF), 3) it plays an important role in metastasis through modulating epithelial-
mesenchymal transition (EMT), and 4) it can change normal cells’ metabolism to that of tumor 
cells through affecting components involved in glucose uptake such as glucose transporter 3 
(GLUT3) [Xia et al. 2014].  
This project analyzes the relative importance of each of NF-κB’s five component proteins 
on the transcription factor’s activity. Each subunit protein is degraded via a method called RNA 
interference (RNAi). RNAi is a convenient way of silencing a target protein through binding and 
destroying the protein’s mRNA, thereby preventing it from being translated. To summarize the 
mechanism shortly, double-stranded RNAs (dsRNAs) get processed into 21- and 22-nucleotide 
fragments, which is the optimum length to carry out RNAi. These fragments are then inserted 
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into cells, bind with complimentary mRNAs, and mediate RNA nuclease attachment which leads 
to the target sequence degradation [Elibashir, et al. 2001].  
Extensive research has already been done on the connection between NF-κB and breast 
cancer. A study done on 82 breast cancer patients found that 55 patients’ cancer cells exhibited 
higher level of NF-κB activity than normal breast cells (p<0.005) [Hou, et al, 2003]. Another 
study performed a mutation analysis on 36 candidate breast cancer genes in 96 human breast 
cancer tissues. The genes were amplified via polymerase chain reaction (PCR) and sequenced. 
Compared to normal breast tissue genes, the cancer genes, which included NF-kB, contained 28 
mutations, implying that mutations in NF-kB family are likely linked to breast cancer 
development [Jiao, et al, 2012]. 
Analysis of five breast cancer cell lines (MCF7, T47D, MDA213, SKBR3, and BT474) 
through electrophoretic mobility shift assays (EMSAs) revealed that although these cell lines 
showed increased activation of NF-kB, not all of NF-kB’s subunits were increased in 
proportional amount. Namely, p50, p52, and c-Rel were shown to be the predominant subunits in 
these cell lines [Cogswell, et al. 2000]. A similar study that analyzed the expression of breast 
tumors’ several markers, which included NF-kB, found that expression levels of p50 and p65 
were correlated with breast cancer [Shapochka, et al. 2012]. These results suggest that NF-kB’s 
five component proteins may not have an equal contribution in cancer development.   
This project is unique in that it attempts to find NF-kB’s extent of influence in 
glioblastoma. Along with the previous studies done with breast cancer, this research will add 
further knowledge on the relationship between NF-kB and cancer.  
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Methods 
Cell Culture 
U87MG glioblastoma cells (ATCC) were grown in Minimal Essential Medium (MEM) 
(Invitrogen) supplemented with 10% Fetal Bovine Serum (FBS) and penicillin/streptomycin 
antibiotics (Invitrogen). Stock dishes of cells (100 mm) were maintained at 37
0
C and 5% CO2 
and media was changed three times per week. Approximately twice a week cells were sub-
cultured using 0.05% trypsin-EDTA for five minutes to remove cells from the dishes and 
dividing them into new 100 mm dishes. Experimental dishes were sub-cultured at 500,000 
cells/ml in 60 mm cell culture dishes (Nunc). 
 
Transfection 
Transfection reaction was set up using 100 l of MEM without FBS, 6 l of FuGene 6 
(Roche) transfection reagent and 5 l of DNA (p50, p52, p65, c-Rel or RelB). This was 
incubated at room temperature (RT) for 30 minutes. Media was removed from the 60 mm cell 
culture dish containing 500,000 cells/ml and replaced with 1.5 ml of MEM without FBS. 
Absence of FBS ensured that the cells wouldn’t divide. At the end of the incubation period, the 
transfection mixture was added to the cells. After 4 hours, 1.5ml of MEM with FBS was placed 
onto the cells to allow them to resume division. Cells to be used for reporter gene assay 
additionally had a pTAL control plasmid or pNF-kB plasmid transfected at the same time as the 
DNA. Control reactions contained everything except the DNA. 
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Western Blot 
24-hours post-transfection cells were collected for protein analysis. Media was removed 
from the dishes, which were washed with ice-cold phosphate buffered saline (PBS). 1 ml of cell 
lysis solution (20mM Tris HCl pH 7.5, 150 mM NaCl, 1mM Na2EDTA, 1 mM EGTA, 1% 
Triton, 2.5 mM sodium pyrophosphate, 1mM b-glycerophosphate, 1mM Na3VO4, 1 mg/ml 
leupeptin; Cell Signaling) was added to the cells in the dish, and the dish was incubated for 5 
minutes on ice. Cells were scraped off of the plate and transferred to a 1.5 ml microcentrifuge 
tube. The tube was centrifuged for 5 minutes at maximum rpm. The supernatant was transferred 
to a new 1.5 ml microcentrifuge tube and stored at -80
0
C until needed.  
Electrophoresis of the protein samples was done using an X Cell SureLock 
electrophoresis chamber (Novex) and a Bio-Rad power pac basic. 20l of protein were placed 
into individual 0.65ml tubes and 1/3 volume of Nupage LDS 2x sample buffer (Invitrogen) was 
added to each tube. The samples were boiled for 5 minutes to induce denaturation and then 
loaded into a 4-12% polyacrylamide gel (Invitrogen) with 1x Nupage MOPS SDS running buffer 
(Invitrogen) with 0.0025% Nupage antioxidants (Invitrogen). The gel was electrophoresed for 2 
hours at 200 V in an ice bath.   
The next step was to transfer the proteins to a PVDF (polyvinylidene fluoride) 
membrane. The gel was removed from the cassette and placed into an electric transfer apparatus 
with the PVDF membrane and Tris-glycine transfer buffer (84mM Tris, 1M glycine). The protein 
transfer was conducted for 3 hours, 20 volts in an ice bath.   
At the end of the transfer, a western blot was performed. The PVDF membrane was 
blocked using 2% skim milk for 1 hour with shaking at RT followed by incubation with the 
primary antibody (p50, p52, p65, c-Rel or RelB) 1:1000 dilution for 1 hour with shaking at RT.  
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The membrane was washed with TBST (Tris buffered saline with 1% Tween 20) for 5 minutes, 
10 minutes and 15 minutes with shaking.  The membrane was then incubated for 1 hour with 
shaking in the secondary antibody (goat anti-rabbit or goat anti-mouse) 1:1000 dilution at RT.  
The membrane was again washed as above.  Detection of bands was performed in a darkroom 
using the ECL chemiluminescent kit (Amersham) according to directions.  Briefly, 1ml of each 
solution (A and B) were mixed together and incubated on the membrane for 1 minute in the light.  
The membrane was exposed to Kodak x-ray film for 30 seconds to 1 minute.  The film was then 
developed and fixed for 3 minutes each with washing between developing and fixing. 
Antibody Manufacturer Grown In 
c-Rel Santa Cruz Rabbit (polyclonal) 
p50 Santa Cruz Rabbit (polyclonal) 
p52 Santa Cruz Rabbit (polyclonal) 
p65 Santa Cruz Rabbit (polyclonal) 
RelB Santa Cruz Mouse (monoclonal) 
 
Secreted Alkaline Phosphatase Assay (SEAP) 
U-87 MG cells were transfected with 2g of shRNA plasmid DNA (p50, p52, p65, c-Rel 
or RelB) and 2g of reporter plasmid DNA (either pNF-kB SEAP or pTAL; Clontech) in 60 mm 
dishes. Twenty-four hours after transfection the medium was removed and centrifuged for 5 
minutes at room temperature and maximum rpm. The supernatant was placed into a new tube. 
200 l supernatant and 200 l of 1X dilution buffer from the Great Escape kit (Clontech) were 
put into 0.65 ml tubes and vortexed. These tubes were incubated at 650C for 30 minutes. 100 l 
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of the content was placed into a 1.5 ml microcentrifuge tube and 99 l of assay buffer (1M 
diethanolamine, 0.05M MgCl2, 0.1M homoarginine) and 1 ml of 4-methylumbelliferyl 
phosphate (Clontech) were added to each tube. The tubes were incubated at room temperature in 
the dark for 1 hour. At the end of the incubation, the plate was read with a fluorometer with 
excitation at 360nm wavelength and emission at 449nm wavelength. The assay was read in 
triplicate for each tube and averaged. A graph was generated from the data. A Student’s t-test, 
standard deviation and standard error tests were performed. This assay was repeated in triplicate. 
The remaining medium was stored at -800C. 
 
Results 
 
Graph 1) The graph shows the result of t-test done on SEAP result. Only p50 and p52 produced significant NF-κB 
reduction. Obvious reduction is not seen for RelB and c-Rel 
Graph 1 shows SEAP result. SEAP assay indicated that only degradation of p50 and p52 
managed to significantly reduce NF-κB activity (p<0.05). Although degradation of p65 produced 
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drop in NF-κB activity, the decrease was not statistically significant. Degradation of RelB and c-
Rel failed to produce any noticeable influence on the transcription factor.  
Graph 2) The graph shows the cell 
count of the transfected cell cultures. 
Only c-Rel produced significant 
reduction in cell count (p<0.05). 
Green bar indicates # of alive cells, 
and blue bar indicates # of dead cells 
 
 
 
 
 
Graph 3) The graph shows the 
percentage cell death 
 
 
 
 
 
 
 
The cell count was somewhat surprising in that it did not reflect the result of SEAP assay. 
As Graph 2 summarizes, only degradation of c-Rel brought about significant reduction in cell 
number. But it is worth noticing in Graph 3 that the percentage cell death of p50 and p52 is 45% 
and 55%, respectively.  
Western blot failed to confirm whether or not proper protein degradation had taken place. 
Only cells subjected to p65 degradation gave a readable Western image, while those subjected to 
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the remaining four did not produce a good image. On top of this, the p65 Western image did not 
show that the expected protein degradation had occurred. Theoretically lighter bands should 
appear for the experimental than for the control. But not much of a color difference between 
p65’s experimental and control could be detected. Data not shown.  
 
Discussion 
 The main weakness of the project is the discrepancy between the SEAP data and cell 
count. Although the SEAP data and cell count did not match up, this difference is not a 
discouraging one. First of all, the SEAP result somewhat corroborated previous studies on breast 
cancer that found that p50, p52, and c-Rel seemed to play comparatively more important role for 
NF-kB activity than p65 and RelB. SEAP assay and cell count indicated that p50, p52, and c-Rel 
were correlated with U87MG glioblastoma cells’ NF-kB activity. While this finding does not 
perfectly reflect that of breast cancer studies, the common ground between the two suggests that 
there is some reason to believe in the validity of this research.  
 In addition, the SEAP result does not actually prove that the project entails problems. 
Two things have to be considered: to begin with, transfection efficiency is quite low; second, 
during the transfection step, cells that are being transfected express different amounts of NF-kB. 
Say that there are two dishes, for instance, in which half the cells is overexpressing NF-kB and 
another half is only slightly overexpressing NF-kB. It may very well result that in Dish 1, 
majority of transfected cells came from those overexpressing NF-kB, while transfected cells of 
Dish 2 equally came from those overexpressing and only slightly overexpressing NF-kB. 
Performing SEAP assay on these two plates would yield very different results, with Dish 1 
appearing to have a better outcome. The same situation applies for Western blot as well. As a 
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result, the inconsistent SEAP result and failure to procure supporting Western images could be 
attributed to the nature of the assays. The only way to eliminate this variability is having a large 
enough sample size. This means that another experiment with a bigger sample size is necessary 
in order to validate the current project’s findings and to get more accurate results.   
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